Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
419,197
-
Share change
-
+110,022
-
Total reported value
-
$871,000
-
Put/Call ratio
-
64%
-
Price per share
-
$2.08
-
Number of holders
-
16
-
Value change
-
+$594,961
-
Number of buys
-
16
-
Number of sells
-
1
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2019
As of 31 Mar 2019,
IGC Pharma, Inc. - COM NEW (IGC) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
419,197 shares.
The largest 10 holders included
DEARBORN PARTNERS LLC, BANK OF MONTREAL /CAN/, Creative Planning, GOLDMAN SACHS GROUP INC, SUNTRUST BANKS INC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Cambridge Investment Research Advisors, Inc., TWO SIGMA SECURITIES, LLC, and JANE STREET GROUP, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.